Showing results (2131-2140 of 2,629) with videos related to
Sort By:
Pageof 263
NPJ Genomic Medicine|June 13, 2020
Persistent STAG2 mutation despite multimodal therapy in recurrent pediatric glioblastomaChristopher S Hong, Juan C Vasquez, Adam J Kundishora, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 3, 2003
West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature reviewDavid S Hong, Kalen L Jacobson, Issam I Raad, et al.Molecular Cancer Therapeutics|January 11, 2011
PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitorsFilip Janku, Apostolia M Tsimberidou, Ignacio Garrido-Laguna, et al.The Oncologist|December 19, 2018
Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision AnalysisJin G Choi, Ryan D Nipp, Angela Tramontano, et al.Clinical Pharmacology and Therapeutics|February 26, 2014
Aspirin decreases systemic exposure to clopidogrel through modulation of P-glycoprotein but does not alter its antithrombotic activityJ Oh, D Shin, K S Lim, et al.Neurosurgery|June 24, 2024
Assessing Mobility in Patients With Glioblastoma Using Digital Phenotyping-Piloting the Digital Assessment in Neuro-OncologyNoah L A Nawabi, Patrick Emedom-Nnamdi, John L Kilgallon, et al.The Journal of Allergy and Clinical Immunology|November 6, 2024
Association of CD19+-targeted chimeric antigen receptor (CAR) T-cell therapy with hypogammaglobulinemia, infection, and mortalityNatalia M Sutherland, Baijun Zhou, Lingxiao Zhang, et al.Oncogene|January 30, 2007
Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomasD W Dawson, J S Hong, R R Shen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2023
A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or LymphomasMrinal M Gounder, Todd M Bauer, Gary K Schwartz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2012
PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutationsFilip Janku, Jennifer J Wheler, Shannon N Westin, et al.Pageof 263